What You Should Know:
– Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company (“New Diabetes Company”).
– The move aims to create a more focused Medtronic,…
Continue Reading
Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030.The manufacturing hub will produce Roche’s continuous glucose monitoring (CGM) systems for diabetes management.
The center will include…
Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
Chronic care management company Omada Health on Friday filed an S-1 with the U.S. Securities and Exchange Commission (SEC) to go public, making it the second digital health company to seek an IPO this…
Continue Reading
Chronic care management company Omada Health filed an S-1 with the Securities and Exchange Commission (SEC) to go public on Friday, making it the second digital health company to seek an IPO this year. The…
Continue Reading
What You Should Know:
– Virtual care company Omada Health filed for an initial public offering (IPO) on Friday, according to the SEC filing.
– Founded in 2012, Omada specializes in virtual care programs designed to…
Continue Reading
What You Should Know:
– ŌURA, the creator of the leading smart ring, today announced a significant expansion of its health tracking capabilities with the introduction of two new AI-driven metabolic health features: Meals and…
Continue Reading
Background: The digital education platform Doctorvice (iKooB Inc.) offers face-to-face physician-patient education during outpatient clinic visits, remote glucose monitoring, and the delivery of educational messages, and is expected to be effective for personalized diabetes…
Continue Reading
What You Should Know:
– Sequel Med Tech, LLC, known for its innovative insulin delivery technology, and Senseonics Holdings, Inc., developer of long-term implantable continuous glucose monitoring (CGM) systems, announced a significant commercial development agreement.
–…
Continue Reading
Early Innovation Matters: What I Learned Building a Glucose Sensor in High SchoolBy Max Kopp
Max Kopp is a high school researcher who is focused on biomedical engineering and non-invasive sensing systems. He is…
